FindTrial
Sign In

Effect of insulins (a chemical in our body which decreases blood sugar) sugar lowering effect in COVID-19 patients

Association between baseline insulin resistance and hospital mortality in moderate to severe non- diabetic COVID-19 patients: An Observational Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/07/026474
Enrollment
125
Registered
2020-07-10
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

Intervention1: Nil: Nil Control Intervention1: Nil: Nil

Sponsors

Dr Souvik Maitra
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adult patients (aged between 18 to 80y), fulfilling WHO case definition of COVID-19 infection and moderate to severe or critically ill will be included in this study.

Exclusion criteria

Exclusion criteria: 1. Patientsâ?? refusal 2. Mild COVID-19 infection. 3. Unproven COVID-19 infection. 4. Patients with known diabetes mellitus as per ADA 2010 criteria 5. Patients on steroids

Design outcomes

Primary

MeasureTime frame
To know whether Insulin Resistance measured by HOMA Insulin Resistance (IR) score can predict in-hospital mortalityTimepoint: Till hospital discharge—

Secondary

MeasureTime frame
HOMA IR score can predict prolonged hospital stay (defined by a duration of more than 21 days) in these patients and serum glucagon and serum cortisol can predict mortality or prolonged hospital stay.Timepoint: Till hospital discharge—

Countries

India

Contacts

Public ContactDr Souvik Maitra

All India Institute of Medical Sciences, New Delhi

souvikmaitra@live.com08146727891

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026